Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

By sjmartinez • April 28, 2023

Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824. PMID: 37109162.

Tags: cardiac remodeling, cardiovascular outcomes, Chronic kidney disease, glomerular pressure, heart failure, mechanism of action, Nephrology, Publications, renal outcomes, sodium-glucose cotransporter-2 inhibitors, sympathetic nervous system, Type 2 diabetes

A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure

Leong M, Dai T, Tong L, Nast CC. A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin[...]

CJASN: A Prelude to the Future

Rhee CM; CJASN Editorial Team. CJASN: A Prelude to the Future. Clin J Am Soc Nephrol. 2024 Nov 7. doi: 10.2215/CJN.0000000613. Epub ahead of print.[...]

Establishing a peritoneal dialysis technique survival core outcome measure: A standardised outcomes in nephrology-peritoneal dialysis consensus workshop report

Elphick EH, Manera KE, Viecelli AK, Craig JC, Cho Y, Ju A, Shen JI, Wilkie M, Anumudu S, Boudville N, Chow JS, Davies SJ, Gooden[...]